Table 3. The correlation matrix of inter-subset for the first-episode drug naive MDD patients.
First-episode drug naive group (n = 36) |
DET (n = 33 |
IDN (n = 36) |
OCL (n = 35) |
TWOB (n = 36) |
GML (n = 34) |
ISL (n = 36) |
SEC (n = 35) |
CPAL (n = 34) |
Composite (n = 36) |
|
---|---|---|---|---|---|---|---|---|---|---|
HAMD (n = 29) |
Pearson Correlation | 0.085 | 0.294 | -0.415* | -0.218 | 0.230 | -0.265 | -0.352 | 0.302 | -0.227 |
Sig. (2-tailed) | 0.680 | 0.122 | 0.028 | 0.256 | 0.249 | 0.164 | 0.061 | 0.126 | 0.237 | |
HAMA (n = 29) |
Pearson Correlation | 0.173 | 0.238 | -0.376* | -0.236 | 0.109 | -0.129 | -0.381* | 0.112 | -0.268 |
Sig. (2-tailed) | 0.398 | 0.214 | 0.049 | 0.217 | 0.588 | 0.504 | 0.041 | 0.578 | 0.160 | |
MADRS (n = 29) |
Pearson Correlation | 0.166 | 0.136 | -0.202 | -0.268 | -0.061 | -0.177 | -0.293 | 0.397* | -0.215 |
Sig. (2-tailed) | 0.418 | 0.483 | 0.303 | 0.160 | 0.762 | 0.358 | 0.123 | 0.041 | 0.263 | |
QOL (n = 29) |
Pearson Correlation | -0.388* | -0.055 | 0.085 | -0.212 | 0.160 | 0.154 | -0.079 | -0.057 | -0.080 |
Sig. (2-tailed) | 0.050 | 0.776 | 0.667 | 0.269 | 0.424 | 0.426 | 0.685 | 0.776 | 0.680 | |
SASS (n = 29) |
Pearson Correlation | -0.223 | 0.041 | -0.023 | -0.164 | 0.001 | 0.027 | -0.254 | 0.089 | -0.140 |
Sig. (2-tailed) | 0.272 | 0.832 | 0.907 | 0.394 | 0.995 | 0.889 | 0.183 | 0.660 | 0.470 | |
CWRT (n = 29) |
Pearson Correlation | -0.077 | -0.261 | -0.028 | 0.073 | -0.083 | 0.323 | 0.199 | -0.425* | -0.010 |
Sig. (2-tailed) | 0.708 | 0.171 | 0.888 | 0.708 | 0.681 | 0.088 | 0.302 | 0.027 | 0.958 |
*p<0.05